Traitement antibiotique des pneumonies ... - Infectiologie

More documents

Recommendations

Info

β-lactam lactam or β-lactam lactam + AMG in Immunocompetent Patients (P. aeruginosa) aeruginosa All cause fatality (2 studies, 29 patients) RR 1.5 (0.07-32.84) Clinical failure (12 studies, 302 patients) RR 1.9 (0.65-1.83) Paul et al BMJ 2004, Online First bmj.com
Page 1 and 2: Traitement antibiotique des pneumon
Page 3 and 4: VAP Mortality and Appropriateness o
Page 5 and 6: Pathogens with Inappropriate Therap
Page 7 and 8: Bactéries Bact ries responsables d
Page 9 and 10: Early-onset Early onset vs Late-ons
Page 11: Variations in Etiology of VAP acros
Page 17 and 18: HAP ATS 2005 . No risk factors for
Page 19 and 20: Objectifs pK/pD Cmax/MIC > 20 AUC 2
Page 21: Bacteremia : All cause fatality Saf
Page 27: Pseudomonas : Combination? Combinat
Page 33 and 34: Synercid ® (quinopristine quinopri
Page 35: Linézolide : études de phase III
Page 39 and 40: Bactéries Bact ries anaérobies an
Page 41 and 42: Antibiothérapie Antibioth rapie pr
Page 43 and 44: Durée Dur e du traitement Traiteme
Page 46 and 47: Pseudomonas : Monotherapy ? 59% n =
Page 48 and 49: Traitement des pneumonies nosocomia
Page 50 and 51: NEWER QUINOLONE AND PENICILLIN- PEN
Page 52 and 53: Facteurs de risques particuliers fa
Page 54 and 55: Indications (raisonnables ?) d ’u
Page 56 and 57: PROTOCOLE II
Page 58 and 59: Adequate Antibiotic Therapy of Pneu
Page 60 and 61: Situations prédisposant pr disposa
Page 62 and 63: Situations prédisposant pr disposa
Page 64 and 65: Pneumonie nosocomiale, de gravité
Page 66 and 67: CIPROFLOXACIN AND S. PNEUMONIAE Sim

Traitement antibiotique des pneumonies ... - Infectiologie

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?